基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Feghali-Bostwick leads a team of clinical and basic scientists focusing on the pathogenic mechanisms underlying fibrosis whose goal is to identify novel targets for therapy and develop new anti-fibrotic strategies for scleroderma/systemic sclerosis, idiopathic pulmonary fibrosis, and other fibrosing conditions. Dr. Feghali-Bostwick also contributes to the mentoring of young physician and academic scientists.
Research Interests
Papers共 117 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Sclerodermapp.161-169, (2024)
BIOMEDICINESno. 1 (2024)
Adegboyega Timothy Adewale,Shailza Sharma,Joe Mouawad,Xinh-Xinh Nguyen,Amy D Bradshaw,Carol Feghali-Bostwick
Matrix biology : journal of the International Society for Matrix Biology (2024)
iScienceno. 6 (2024): 110010-110010
Arthritis & rheumatology (Hoboken, N.J.)no. 12 (2023): 2228-2239
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 14 (2023): 11234-11234
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn